These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 9354968
21. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ. Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155 [Abstract] [Full Text] [Related]
22. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin. Medeiros MA, Armôa GR, Dellagostin OA, McIntosh D. Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859 [Abstract] [Full Text] [Related]
23. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model. Carter CR, Dagg BM, Whitmore KM, Keeble JR, Asokanathan C, Xing D, Walker KB. Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514 [Abstract] [Full Text] [Related]
24. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. Geurtsen J, Banus HA, Gremmer ER, Ferguson H, de la Fonteyne-Blankestijn LJ, Vermeulen JP, Dormans JA, Tommassen J, van der Ley P, Mooi FR, Vandebriel RJ. Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641 [Abstract] [Full Text] [Related]
25. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines. Hale C, Humphreys IR, Hussell T, Bowe F, Clare S, Pickard D, Preston A, Del Giudice G, Dougan G. Vaccine; 2004 Sep 09; 22(27-28):3595-602. PubMed ID: 15315838 [Abstract] [Full Text] [Related]
26. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Mielcarek N, Riveau G, Remoué F, Antoine R, Capron A, Locht C. Nat Biotechnol; 1998 May 09; 16(5):454-7. PubMed ID: 9592394 [Abstract] [Full Text] [Related]
28. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. David S, van Furth R, Mooi FR. Vaccine; 2004 May 07; 22(15-16):1892-8. PubMed ID: 15121300 [Abstract] [Full Text] [Related]
37. The reactivity of mice after hyperimmunization with Bordetella pertussis. David C, Pozsgi N, Andreescu V, Caffé I. Arch Roum Pathol Exp Microbiol; 1974 Apr 07; 33(3-4):313-8. PubMed ID: 4377531 [No Abstract] [Full Text] [Related]
38. Bordetella pertussis Whole Cell Immunization, Unlike Acellular Immunization, Mimics Naïve Infection by Driving Hematopoietic Stem and Progenitor Cell Expansion in Mice. Varney ME, Boehm DT, DeRoos K, Nowak ES, Wong TY, Sen-Kilic E, Bradford SD, Elkins C, Epperly MS, Witt WT, Barbier M, Damron FH. Front Immunol; 2018 Apr 07; 9():2376. PubMed ID: 30405604 [Abstract] [Full Text] [Related]
40. Inhibition of the immune response to pertussis vaccine during Plasmodium berghei yoelii infection in mice. Viens P, Tarzaali A, Quevillon M. Am J Trop Med Hyg; 1974 Sep 07; 23(5):846-9. PubMed ID: 4375413 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]